Divis Labs gets US FDA import alert
The company has announced that it is working with third party consultants to address concerns of USFDA
Author
US FDA to lift import alert on Mohali plant
The move will clear the path for Sun Pharma to supply approved products from the Mohali facility to the US market
Branded heart, diabetes drugs much costlier than generic ones
The minster also mentioned that in the diabetes drugs segment the average price of leading brands of some medicines is also higher…
Mrida Greens expands its plant extracts business
Adds 5 more aqua-based nutrient extracts to its existing aloe vera products
Mrida Greens & Organics, a Mrida Group entity…
DIA’s pharmacovigilance conference to be held in Mumbai
The conference will have renowned pharmacovigilance experts
Dr Ajaz Hussain appointed as Senior Advisor, Risk Consulting, KPMG in India
He will guide KPMG on risk consulting practice as an industry and regulatory specialist while defining a compliance roadmap
Indian pharma industry continues to face headwinds; aggregate growth expected to come down to single…
Increased regulatory scrutiny and consolidation of supply chain in the US market resulting in pricing pressures along with…
New Access to Vaccines Index reveals first landscape of vaccine company actions to improve…
The independent index, analysed companies’ R&D pipelines, identifying nearly 90 vaccine projects for high-priority diseases…
Regulators stress need to build a culture of quality at IPA meet
CDSCO, US FDA, MHRA, EMA, EDQM officials share updates in regulatory guidances, identify weak spots and suggest ways to bridge…
Zydus Cadila to launch influenza fighting vaccine in India
The vaccine provides protection from four influenza viruses -- H1N1, H3N2, Type B (Brisbane)
Drug firm Zydus Cadila has received…